BICX · BioCorRx Inc.
$0.21
+0.01 (+4.48%)
At close · Aug 31
View the 10-Q filed Aug 14, 2026
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As of June 30, 2026, the Company had cash of $21,237 and working capital deficit of $8,231,326. During the six months ended June 30, 2026, the Company used net cash in operating activities of $873,260. The Company has incurred net losses since inception. These conditions raise substantial doubt about the Company's ability to continue as a going concern for the next twelve-month period since the date of the financial statements were issued.”View the 10-Q filed Aug 14, 2026
Customer concentration
— top 2 customers 100% of revenue
2 customers — 100% of revenue (three months ended June 30, 2026)
“The Company's revenues earned from sale of products and services for the three months ended June 30, 2026 included 100% from two customers of the Company's total revenues.”
2 customers — 99% of revenue (three months ended June 30, 2025)
“The Company's revenues earned from sale of products and services for the three months ended June 30, 2025 included 99% from two customers of the Company's total revenues.”
Market Cap
$5.98M
Shares
29.76M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$797.24K
+10301.1%
FY2025
Net Income
-$3.44M
+32.6%
FY2025
Gross Margin
77.6%
+24pp
FY2013
Operating Margin
-606.04%
+66223.8pp
FY2025
Diluted EPS
-$0.19
+61.2%
FY2025
Operating Cash Flow
-$2.3M
-109.6%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $786.62K | $797.24K | $7665 | $89.16K | $213.84K | $48.27K | $122.62K | $240.26K | $376.66K | $657.27K | $701.77K | $924.73K | $1.17M | $714.96K | $868.16K | $771.76K | $144.4K | — | |
| — | — | — | — | — | -$565.68K | -$510.96K | — | — | — | — | — | — | — | — | — | — | — | |
| $115.65K | — | $105.98K | $3577 | $7419 | $2384 | $34.28K | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | $1667 | $35.99K | $15.28K | $5881 | $95.95K | $81.67K | $170.95K | $323.61K | $175.43K | $151.97K | $220.96K | $160.19K | $402.48K | $400.41K | $156.22K | — | |
| $183.11K | — | — | — | — | — | — | — | — | — | — | — | — | $554.78K | $465.68K | $371.35K | -$11.82K | — | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | 77.6% | 53.64% | 48.12% | -8.18% | — | |
| $2.37M | $1.77M | $1.48M | $891.06K | $1.46M | $1.61M | $4.27M | $1.13M | $151.77K | $450.72K | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | $3.74M | $3.17M | $4.57M | $4.42M | $2.74M | $2.55M | $2.13M | $3.87M | $2.92M | $1.09M | $712.68K | — | — | |
| $3.15M | $3.79M | $3.61M | $2.88M | $3.41M | $3.74M | — | — | — | — | — | — | — | — | — | $713.58K | $119.95K | — | |
| — | — | — | — | — | — | — | $11.99K | — | — | — | — | — | — | — | — | — | — | |
| -$31.79K | $44K | $33.15K | $26.81K | $27.45K | $64.33K | $77.25K | $29.41K | $7353 | $33.89K | $30.25K | $125.07K | $135.49K | $135.51K | $1988 | $2191 | $21.75K | — | |
| $5.69M | $5.63M | $5.13M | $3.88M | $4.91M | $5.56M | $7.61M | $5.8M | $5M | $3.55M | $2.88M | $6.04M | $4.22M | $3.22M | $1.09M | $714.87K | $141.7K | — | |
| -$4.9M | -$4.83M | -$5.12M | -$3.79M | -$4.7M | -$5.51M | -$7.49M | -$5.56M | -$4.63M | -$2.89M | -$2.18M | -$5.12M | -$3.05M | — | — | — | — | — | |
| — | -606.04% | -66829.81% | -4248.31% | -2196.96% | -11414.71% | -6109.86% | -2314.7% | -1228.18% | -439.84% | -310.93% | -553.45% | -260.7% | — | — | — | — | — | |
| -$4.93M | -$4.79M | -$5.09M | -$3.76M | -$4.67M | -$5.45M | -$7.41M | -$5.53M | -$4.62M | -$2.86M | -$2.15M | -$4.99M | -$2.92M | — | — | — | — | — | |
| $160.77K | $223.85K | $776.78K | $194.04K | $150.97K | $19.42K | $510.96K | $1.62M | -$1.96M | $11.15M | $1.05M | $377.09K | $352.8K | $310.4K | — | — | — | — | |
| $1.76M | $1.32M | -$89.6K | $17.31K | $321.16K | $299.47K | $3.99M | -$487.05K | -$1.96M | -$26.81M | -$3.72M | $451.89K | -$75.21K | — | — | — | — | — | |
| -$3.14M | -$3.51M | -$5.21M | -$3.77M | -$4.38M | -$5.21M | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | — | — | — | — | $1600 | $1600 | — | — | — | |
| -$3.15M | -$3.44M | -$5.11M | -$3.77M | -$4.38M | -$5.21M | -$3.51M | -$6.05M | -$6.58M | -$29.71M | -$5.9M | -$4.67M | -$3.13M | -$3.84M | -$885.81K | -$408.97K | -$154.59K | -$13.2K | |
| — | -431.5% | -66616.1% | -4228.9% | -2046.77% | -10794.33% | -2859.63% | -2517.42% | -1748.11% | -4519.55% | -841.3% | -504.58% | -267.12% | -536.88% | -102.03% | -52.99% | -107.06% | — | |
| $20K | -$68.62K | -$105.98K | — | — | -$5.28M | -$3.47M | -$6.04M | -$6.51M | -$29.71M | — | — | — | — | — | — | — | — | |
| — | — | -$5.11M | -$3.77M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| USD/shares | -$0.12 | -$0.19 | -$0.49 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| shares | — | — | — | — | — | 6.49M | 5.38M | 3.52M | 2.51M | 2.33M | 170.25M | 155.49M | 138.88M | 117.38M | 106.15M | 50.56M | 37M | — |
| shares | — | 18.49M | 10.46M | 2.7M | 1.45M | 1.06M | 1.14M | 1.14M | 2.43M | 1.82M | 250.19M | 26.79M | 17.98M | 15.8M | 106.15M | 50.56M | — | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 0.94×
EV/EBIT
—
P/E (TTM)
—
Peer medians compare against the 10 similar-size Medical Care Facilities companies (of 51 listed).